- Home
- TRMK vs VCEL Comparison
TRMK vs VCEL Comparison
Compare TRMK & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRMK
- VCEL
- Stock Information
- Founded
- TRMK 1889
- VCEL 1989
- Country
- TRMK United States
- VCEL United States
- Employees
- TRMK N/A
- VCEL N/A
- Industry
- TRMK Major Banks
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRMK Finance
- VCEL Health Care
- Exchange
- TRMK Nasdaq
- VCEL Nasdaq
- Market Cap
- TRMK 2.2B
- VCEL 2.1B
- IPO Year
- TRMK 1987
- VCEL 1997
- Fundamental
- Price
- TRMK $38.74
- VCEL $37.98
- Analyst Decision
- TRMK Buy
- VCEL Strong Buy
- Analyst Count
- TRMK 4
- VCEL 8
- Target Price
- TRMK $40.50
- VCEL $62.00
- AVG Volume (30 Days)
- TRMK 341.7K
- VCEL 550.4K
- Earning Date
- TRMK 07-22-2025
- VCEL 07-31-2025
- Dividend Yield
- TRMK 2.48%
- VCEL N/A
- EPS Growth
- TRMK 50.91
- VCEL 521.85
- EPS
- TRMK 3.85
- VCEL 0.05
- Revenue
- TRMK $544,423,000.00
- VCEL $238,541,000.00
- Revenue This Year
- TRMK $57.30
- VCEL $23.03
- Revenue Next Year
- TRMK $3.88
- VCEL $24.52
- P/E Ratio
- TRMK $10.07
- VCEL $730.75
- Revenue Growth
- TRMK N/A
- VCEL 14.80
- 52 Week Low
- TRMK $29.77
- VCEL $34.87
- 52 Week High
- TRMK $40.73
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- TRMK 61.72
- VCEL 42.88
- Support Level
- TRMK $36.82
- VCEL $34.87
- Resistance Level
- TRMK $39.21
- VCEL $37.76
- Average True Range (ATR)
- TRMK 1.03
- VCEL 1.73
- MACD
- TRMK -0.05
- VCEL -0.41
- Stochastic Oscillator
- TRMK 74.00
- VCEL 40.18
About TRMK Trustmark Corporation
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.